GL vs PRI: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. GL and PRI share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined GL and PRI exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Globe Life Inc. is a Texas-based insurance holding company (formerly Torchmark) that underwrites individual life insurance and supplemental health insurance aimed at lower-to-middle-income American families. It sells through captive and exclusive agency channels under subsidiaries including American Income Life, Liberty National, Family Heritage, United American, and the direct-to-consumer Globe Life brand, and reports across life, health, and investment segments. The model emphasizes a large in-force book of small-face-amount policies with high persistency, which produces recurring premium and a sizable investment portfolio.

Full GL guide

Primerica sells simple term life insurance it underwrites itself, plus mutual funds, managed accounts, annuities, segregated funds and brokered mortgages that other firms manufacture. What makes the company unusual is the distribution: about 148,600 life-licensed independent representatives, most of them working part time and recruited from the same middle-income communities they sell into. Three segments carry the results. Term Life Insurance produced roughly $444 million of adjusted operating revenue and about $148 million of pre-tax income in the second quarter of 2026, a 21.3% segment margin off an in-force block built up over decades. Investment and Savings Products (ISP) produced about $361 million of revenue and $104 million of pre-tax income on record quarterly sales of roughly $4.4 billion. Corporate and Other Distributed Products, which includes mortgage brokerage and net investment income, adds a small remainder. The Senior Health segment, built around the e-TeleQuote Medicare brokerage acquired in 2021, was exited in 2024 and no longer appears in the segment tables.

Full PRI guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• GL drivers: Premium growth across agency divisions; High return on equity and book-value compounding.
• PRI drivers: The investment and savings flywheel; The in-force term life book as the cash engine.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Reputational and legal exposure is the defining risk: the 2024 Fuzzy Panda short report alleged systemic insurance fraud (policies for deceased or fictitious people, forged signatures, unauthorized withdrawals) concentrated in agents at American Income Life, and shareholder and derivative lawsuits alleging the company misled investors remain ongoing even after the DOJ probe closed without action. For PRI, the clearest risk is the distribution model itself, because a life-licensed force that shrinks 3% a year eventually shows up in issued policies, then in in-force premium, then in Term Life earnings.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick GL if you believe its drivers more; PRI if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the GL and PRI guides.

GL. GL trades at a low-teens trailing price-to-earnings multiple, well below the broad market, reflecting both its steady insurance-underwriting profile and the reputational discount lingering from the 2024 allegations. Return on equity in the high teens and book value per share near $77 support a valuation that leans on consistent earnings and buybacks rather than high growth. Figures are approximate and drawn from 2025 results and 2026 quarterly reporting.

PRI. Trailing twelve-month revenue of about $3.43 billion and net income near $796 million work out to roughly $24.90 of diluted earnings per share, which puts the stock around 12 times trailing earnings at a share price in the high $290s. Book value is about $2.52 billion on roughly 30.9 million shares, or close to $82 per share, so the multiple of book sits near 3.7 times, a premium that reflects reported return on equity of 32.1% rather than an insurer-style balance sheet story. Screeners sometimes carry a stale Senior Health segment or a depressed 2024 earnings base, since the e-TeleQuote exit pushed second-quarter 2024 net income to roughly $1 million; the FY2025 figures of $3.29 billion revenue and $22.91 diluted EPS are the cleaner comparison.

Headline figures (approximate, JULY 2026): GL shows revenue (ttm) ~$6.0B, market cap ~$13.9B, diluted eps (2025) ~$14.07, 2026 eps guidance ~$15.40 to $15.90; PRI shows revenue (ttm) ~$3.43B, net income (ttm) ~$796M (~23% net margin), diluted eps (ttm) ~$24.90, market cap / p/e ~$9.2B / ~12x trailing.

GL and PRI are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined GL and PRI exposure against your real portfolio. It is not an investment adviser.